668 related articles for article (PubMed ID: 18963541)
1. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies.
Bisdas S; Baghi M; Smolarz A; Pihno NC; Lehnert T; Knecht R; Mack MG; Vogl TJ; Tuerkay S; Koh TS
Invest Radiol; 2007 Mar; 42(3):172-9. PubMed ID: 17287647
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
4. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
7. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.
Been MJ; Watkins J; Manz RM; Gentry LR; Leverson GE; Harari PM; Hartig GK
Laryngoscope; 2008 Aug; 118(8):1377-82. PubMed ID: 18418275
[TBL] [Abstract][Full Text] [Related]
8. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx].
Rohrmeier M; Langnickel R; Hilpert P
HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010
[TBL] [Abstract][Full Text] [Related]
9. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
[TBL] [Abstract][Full Text] [Related]
11. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
12. Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements.
Bisdas S; Rumboldt Z; Wagenblast J; Baghi M; Koh TS; Hambek M; Vogl TJ; Mack MG
AJNR Am J Neuroradiol; 2009 Apr; 30(4):793-9. PubMed ID: 19351906
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the oropharynx and hypopharynx.
Lin DT; Cohen SM; Coppit GL; Burkey BB
Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
[TBL] [Abstract][Full Text] [Related]
14. [Simultaneous squamous cell carcinomas of the oral cavity and oropharynx].
Ricard AS; Majoufre-Lefebvre C; Demeaux H; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):509-12. PubMed ID: 17881023
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction after surgery and chemoradiation of head-and-neck squamous cell carcinoma (HNSCC), using baseline perfusion computed tomography (CT) microcirculatory parameters vs. tumor volume.
Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1307; author reply 1307. PubMed ID: 19545798
[No Abstract] [Full Text] [Related]
17. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
[TBL] [Abstract][Full Text] [Related]
19. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.
Bisdas S; Spicer K; Rumboldt Z
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1376-81. PubMed ID: 18483187
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
